Advances in vaccination against Helicobacter pylori.

A vaccination against Helicobacter pylori may represent both prophylactic and therapeutic approaches to the control of H. pylori infection. Different protective H. pylori-derived antigens, such as urease, vacuolating cytotoxin A, cytotoxin-associated antigen, neutrophil-activating protein and others can be produced at low cost in prokaryote expression systems and most of these antigens have already been administered to humans and shown to be safe. The recent development by Graham et al. of the model of H. pylori challenge in humans, the recent published clinical trials and the last insight generated in animal models of H. pylori infection regarding the immune mechanisms leading to vaccine-induced Helicobacter clearance will facilitate the evaluation of immunogenicity and efficacy of H. pylori vaccine candidates in Phase II and III clinical trials.

Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicity.

Soluble MHC-peptide (pMHC) complexes induce intracellular calcium mobilization, diverse phosphorylation events, and death of CD8+ CTL, given that they are at least dimeric and co-engage CD8. By testing dimeric, tetrameric, and octameric pMHC complexes containing spacers of different lengths, we show that their ability to activate CTL decreases as the distance between their subunit MHC complexes increases. Remarkably, pMHC complexes containing long rigid polyproline spacers (> or =80 A) inhibit target cell killing by cloned S14 CTL in a dose- and valence-dependent manner. Long octameric pMHC complexes abolished target cell lysis, even very strong lysis, at nanomolar concentrations. By contrast, an altered peptide ligand antagonist was only weakly inhibitory and only at high concentrations. Long D(b)-gp33 complexes strongly and specifically inhibited the D(b)-restricted lymphocytic choriomeningitis virus CTL response in vitro and in vivo. We show that complications related to transfer of peptide from soluble to cell-associated MHC molecules can be circumvented by using covalent pMHC complexes. Long pMHC complexes efficiently inhibited CTL target cell conjugate formation by interfering with TCR-mediated activation of LFA-1. Such reagents provide a new and powerful means to inhibit Ag-specific CTL responses and hence should be useful to blunt autoimmune disorders such as diabetes type I.

The tumor microenvironment and its contribution to tumor evolution toward metastasis.

Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival through the activation of oncogenes and inactivation of tumor suppressor genes. Nevertheless, the formation of a clinically relevant tumor requires support from the surrounding normal stroma, also referred to as the tumor microenvironment. Carcinoma-associated fibroblasts, leukocytes, bone marrow-derived cells, blood and lymphatic vascular endothelial cells present within the tumor microenvironment contribute to tumor progression. Recent evidence indicates that the microenvironment provides essential cues to the maintenance of cancer stem cells/cancer initiating cells and to promote the seeding of cancer cells at metastatic sites. Furthermore, inflammatory cells and immunomodulatory mediators present in the tumor microenvironment polarize host immune response toward specific phenotypes impacting tumor progression. A growing number of studies demonstrate a positive correlation between angiogenesis, carcinoma-associated fibroblasts, and inflammatory infiltrating cells and poor outcome, thereby emphasizing the clinical relevance of the tumor microenvironment to aggressive tumor progression. Thus, the dynamic and reciprocal interactions between tumor cells and cells of the tumor microenvironment orchestrate events critical to tumor evolution toward metastasis, and many cellular and molecular elements of the microenvironment are emerging as attractive targets for therapeutic strategies.

What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?

Tumor-regressions following tumor-associated-antigen vaccination in animal models contrast with the limited clinical outcomes in cancer patients. Most animal studies however used subcutaneous-tumor-models and questions arise as whether these are relevant for tumors growing in mucosae; whether specific mucosal-homing instructions are required; and how this may be influenced by the tumor.

Brain metastasis: opportunity for drug development?

PURPOSE OF REVIEW: Brain metastases are a common clinical problem, and only limited treatment options exist. We review recent advances in medical brain metastasis research with a focus on the most common tumor types associated with secondary brain colonization: melanoma, breast cancer and lung cancer. We speculate on opportunities for drug development in patients with brain metastases, both as a treatment of established disease and as an adjuvant and prophylactic strategy. RECENT FINDINGS: BRAF inhibitors and the immunomodulatory anticytotoxic T-lymphocyte-associated antigen 4 antibody ipilimumab have shown clinically meaningful activity in melanoma patients with brain metastases. In breast cancer, current studies on drug treatment of brain metastases are mainly focusing on human epidermal growth factor receptor 2 targeting agents such as lapatinib. Emerging data seem to implicate a potential role of targeted agents including antiangiogenic compounds, pazopanib, and epithelial growth factor receptor inhibitors for prevention of brain metastasis formation in breast cancer or nonsmall cell lung cancer. SUMMARY: Novel drugs are beginning to enter clinical practice for selected patients with brain metastases. The promising findings from recent studies may fuel more research on brain metastases and their optimal drug treatment.

Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.

Here we report the discovery of and phenotypic characterization of a retinal disorder of unknown origin in adults using clinical, electrophysiological and psychophysical techniques, and to seek the presence of circulating retinal autoantibodies in the sera of these patients. Sixteen patients were identified with progressive bilateral visual loss over a period of months. Ten of the patients were male, and the average age was 55.3 years (range from 43 to 76 years). Known causes such as carcinoma-associated retinopathy, acute zonal occult outer retinopathy and hereditary cone dystrophy appeared unlikely. Investigations included electrophysiology, fundus autofluorescence imaging and psychophysical tests. The sera of these patients were analyzed with indirect immunocytochemistry and Western immunoblot analysis on murine (BALB/c) retinal tissue for the presence of retinal autoantibodies. Bilateral visual loss and photophobia progressed over a period of months to years (average 28.7 months, range 3-67) and subsequently stabilized. No abnormality was observed by biomicroscopy, angiography or autofluorescence imaging. Electrophysiology indicated predominant cone-system dysfunction, either macular or generalized, and post-phototransduction involvement in 9 patients (56%). Photopic and scotopic visual fields and dark adaptation kinetics showed both cone and rod system involvement in all cases. Heterogeneous immunohistochemical staining patterns were seen with the sera of these patients as compared with controls. A majority of the affected patients (9/15) stained with an antinuclear pattern. The retinal autoantibodies from the sera of most patients reacted with the retinal proteins of molecular weight between 34 and 40 kDa. The aetiology of this distinctive retinal disorder therefore appears to be mediated through an autoimmune mechanism.

Regulation of P-selectin glycoprotein ligand 1 (PSGL-1) interactions with selectins : role of the decameric repeats and of the cytoplasmic domain

SUMMARY BACKGROUND: P-selectin glycoprotein ligand 1 (PSGL-1) is a major selectin ligand, mediating leukocyte rolling along inflamed vascular wall. It is a mucin-like homodimer composed of a N-terminal domain which binds selectins, followed by 14-16 decameric repeats (DR), a transmembrane domain and a cytoplasmic tail, which may be involved in regulating leukocyte rolling and in generating intracellular signals, through its binding to moesin and Syk. P- and L-selectin binding is dependent on core-2 O-glycosylation and tyrosine sulfation of PSGL-1 N-terminus. However, a minor part of E-selectin-mediated rolling is dependent on N-terminal O-glycans; additional binding sites may thus be involved. In this project, we studied whether (1) PSGL-1 DR and (2) PSGL-1 cytoplasmic residues which bind moesin, were also involved in the regulation of selectin-dependent rolling. METHODS: Several mutated cDNAs were obtained: (1) PSGL-1 DR were either deleted, or substituted by platelet GPlba macroglycopeptide, (2) Ser-336, -348, Lys-337 and Arg-338 were mutated to alanine; moreover, truncation mutants retaining only 6 or 2 cytoplasmic residues were also generated. Transfected CHO expressing mutant PSGL-1 were tested for their ability to bind soluble selectin chimeras and to support selectin-dependent rolling under flow conditions. RESULTS: (1) Deletion of the DR had a dramatic effect on P- and L-selectin-dependent cell recruitment and rolling stability, which could only partially be compensated for, by GPlba substitution. In addition, we observed that DR create a binding site for E-selectin and thus support PSGL-1-dependent rolling. (2) Flow assays revealed that the moesin-binding site, in particular Ser-336, plays a crucial role in regulating the recruitment, velocity and rolling stability of PSGL-1-expressing cells on P- and L-selectin. CONCLUSIONS: Data presented here highlight the structure -function relationship of PSGL-1 DR. Moreover, they reveal a crucial role for the moesin-binding residues in regulating P-and L-selectin-dependent rolling. RÉSUMÉ CONTEXTE: PSGL-1 (P-selectin glycoprotein ligand 1) est un ligand majeur des sélectines permettant le roulement des leucocytes le long de la paroi vasculaire enflammée. C'est un homodimère de type mucine, composé d'un domaine N-terminal liant les sélectines, suivi de 14-16 répétitions décamèriques (RD), d'un domaine transmembranaire et d'une queue cytoplasmique qui pourrait être impliquée dans la régulation du roulement leucocytaire et la génération de signaux intracellulaires, via sa liaison à la moésine et à Syk. La liaison à la Pet à la L-sélectine dépend de la présentation par le N-terminus de PSGL-1 de O-glycans sur des structures core-2 et de tyrosines sulfatées. Cependant, une fraction mineure du roulement médié par la E-sélectine dépend des O-glycans N-terminaux; des sites de liaisons supplémentaires pourraient donc être impliqués. Dans ce projet, nous avons étudié si (1) les RD de PSGL-1 ainsi que (2) les résidus cytoplasmiques liant la moésine, étaient impliqués dans la régulation du roulement dépendant des sélectines. MÉTHODES: Plusieurs ADN codant des formes mutées de PSGL-1 ont été obtenus: (1) Les RD de PSGL-1 ont été soit ôtées, soit remplacées par le macroglycopeptide de la GPlba plaquettaire, (2) les Ser-336, -348, la Lys-337 et l'Arg-338 ont été mutées en alanine; par ailleurs, des mutants tronqués ne retenant plus que 6 ou 2 résidus cytoplasmiques ont également été générés. Des CHO transfectées exprimant PSGL-1 muté ont été testées pour leur capacité à lier des sélectines chimériques solubles et à soutenir un roulement dépendant des sélectines dans des conditions de flux. RÉSULTATS: (1) La perte des RD a eu un effet dramatique sur le recrutement cellulaire et la stabilité de roulement dépendant des P- et L-sélectine, qui n'a pu être que partiellement compensé par la substitution par la GPlba. De plus, nous avons observé que les RD forment un site de liaison pour la E-sélectine et soutiennent ainsi le roulement dépendant de PSGL-1. (2) Les tests de flux ont révélé que le site de liaison à la moésine, notamment la Ser-336, joue un rôle crucial dans la régulation du recrutement, de la vitesse et de la stabilité du roulement des cellules exprimant PSGL-1 sur les P- et L-sélectine. CONCLUSIONS; Les données présentées ici ont permis d'éclaircir la relation structure -fonction des RD de PSGL-1. Par ailleurs, elles révèlent un rôle crucial pour les résidus liant la moésine dans le roulement dépendant des P- et L-sélectine. RÉSUMÉ DESTINÉ À UN LARGE PUBLIC Pour accomplir ses fonctions, le sang circule sur un réseau de 96'000 kilomètres; ainsi, il approvisionne les cellules de l'organisme en énergie, il transporte diverses substances, il assure la défense contre les pathogènes et il participe à la régulation de la température corporelle. Le sang contient plusieurs types de cellules: la grande majorité sont les globules rouges, auxquels il faut ajouter les plaquettes (dont le rôle est de colmater les lésions vasculaires) et les globules blancs (leucocytes) qui, bien que présents en très faible quantité (moins de 0.01 %), jouent un rôle crucial en cas d'infection ou d'inflammation. Une attaque par un pathogène provoque plusieurs changements (rougeur, chaleur, gonflement, douleur), qui sont des manifestations de l'inflammation. Pour atteindre l'agent infectieux, des globules blancs spécialisés (les granulocytes) doivent quitter la circulation sanguine. Afin de faciliter leur capture, les vaisseaux sanguins vont exprimer des protéines telles que les sélectines, qui sont reconnues par une protéine leucocytaire appelée PSGL-1 (P-selectin glycoprotein ligand 7). L'interaction des sélectines avec PSGL-1 soutient le roulement du globule blanc le long de la paroi vasculaire, à une vitesse très inférieure à celle du flux sanguin. Ce roulement conduit à l'activation du globule blanc par des molécules de l'inflammation, permettant son adhésion ferme, puis son arrêt. Finalement, le granulocyte va migrer à travers la paroi du vaisseau pour atteindre et éliminer les causes de l'inflammation. L'adhésion est un processus intéressant à caractériser, car outre l'inflammation, il est également impliqué dans l'artériosclérose, l'infarctus, la métastatisation et la thrombose. Dans ce travail, nous nous sommes intéressés à définir les rôles des différents domaines de PSGL-1 dans la régulation de son interaction avec les sélectines. En effet, en plus de son extrémité extracellulaire de haute affinité pour les sélectines, PSGL-1 est composé de plusieurs séquences répétées hautement glycosylées et d'une courte région intracellulaire, dont les fonctions n'avaient pas été étudiées auparavant. En créant des formes mutées de PSGL-1, nous avons pu montrer qu'un roulement efficace des leucocytes nécessite la présence des régions répétitives et du domaine intracellulaire au complet.

CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4; CD152) is of pivotal importance for self-tolerance, with deficiency or unfavorable polymorphisms leading to autoimmune disease. Tolerance to self-antigens is achieved through thymic deletion of highly autoreactive conventional T (Tconv) cells and generation of FoxP3(+) regulatory T (Treg) cells. The main costimulatory molecule, CD28, augments the negative selection of Tconv cells and promotes the generation of FoxP3(+) Treg cells. The role of its antagonistic homolog CTLA-4, however, remains a topic of debate. To address this topic, we investigated the thymic development of T cells in the presence and absence of CTLA-4 in a T-cell receptor (TCR) transgenic mouse model specific for the myelin basic protein peptide Ac1-9. We reveal that CTLA-4 is expressed in the corticomedullary region of the thymus. Its absence alters the response of CD4(+)CD8(-) thymocytes to self-antigen recognition, which affects the quantity of the Treg cells generated and broadens the repertoire of peripheral Tconv cells. T-cell repertoire alteration after deletion of CTLA-4 results from changes in TCR Vα and Jα segment selection as well as CDR3α composition in Tconv and Treg cells. CTLA-4, therefore, regulates the early development of self-reactive T cells in the thymus and plays a key role in central tolerance.

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.

Immune responses against tumor-associated antigens rely on efficient epitope presentation. The melanoma-associated antigen (Ag) gp100 contains HLA-A*0201 ligands that are characterized by low to medium binding affinity, among which gp100(209-217) is the most prominent (Kawakami et al., J Immunol 154:3961-3968, 1995). While this epitope is a natural T-cell target, it primes with low-efficiency T-cell responses during immunization. A modified gp100 epitope, gp100(209-217T210M), that contains a Thr to Met substitution at position 2 of the antigenic nonamer is characterized by high binding affinity for HLA-A*0201 and elicits strong and clinically effective T-cell responses. This higher affinity is believed to represent the sole reason for enhanced immunogenicity. Contrasting with this observation is the unpredictable relationship between affinity and immunogenicity observed in other antigen systems. In addition, we noted a striking difference between the capability of endogenously processed gp100(209-217) and gp100(209-217T210M) to induce T-cell responses in an in vitro model. Therefore, we questioned whether factors other than HLA-affinity might play a role in determining the immunogenicity of these epitopes. In the present study, we evaluated the in vitro proteasomal cleavages of 23meric precursor peptides encompassing the native sequence (gp100(201-223)) or the modified sequence (gp100(201-223T210M)). Here we show that the standard proteasome liberates the C-termini of both antigenic peptides but not the N-termini. Quantitative analysis of the digestion products revealed that more of the fragments displaying the final C-termini were produced from the wild-type precursor. However, a stronger TCR engagement was observed when fractions of digested gp100(201-223T210M) were used to activate an HLA-A*0201-expressing target T-cell clone. This difference was also found using separately produced, synthetic nonamers. In conclusion, the high binding affinity of gp100(209-217T210M) seems to compensate for possible differences in proteasomal cleavage at the biological level. Since the final antigenic nonamer is not directly produced by the proteasome, additional further factors may influence the antigenic peptide availability, such as post-proteasomal processing and intracellular peptide transport.

Estudi del procés de neurodegeneració

Les anomenades malalties neurodegeneratives tenen una simptomatologia i unes manifestacions clíniques molt diferents entre elles. No obstant, totes elles convergeixen en el mateix procés final, la neurodegeneració, que es manifestarà en diferents localitzacions o tipus cel·lulars del sistema nerviós. Nosaltres, plantegem la hipòtesi de que els processos moleculars i cel·lulars subjacents a la neurodegeneració són comuns per totes elles. Després de dur a terme un procés de selecció, es decideix treballar amb la malaltia de Parkinson, la d’Alzheimer, l’Esclerosi lateral amiotròfica i l’esclerosi múltiple. Hem pogut determinar que hi ha set processos moleculars o cel·lulars que estan associats al procés de neurodegeneració i que són comuns a totes elles. Havent-les estudiat per separat s’observa que el procés de neurodegeneració consisteix en una fallada en cadena de diferents sistemes moleculars i cel·lulars que tenen com a punt d’origen l’estrès oxidatiu. A aquest estrès s’hi pot arribar de diferents maneres. Una d’elles és l’exposició excessiva a certs metalls, que provoca la pèrdua dels sistemes antioxidants cel·lulars. Degut a això, els mitocondris reben un impacte oxidatiu massa gran i comencen a fallar. El fet que aquest orgànul actuï com a tampó del calci intracel·lular en provoca la seva desregulació, alterant d’aquesta manera el senyal nerviós. En resposta a l’estrès oxidatiu i tèrmic que genera la disfunció mitocondrial, s’activen les Proteïnes de Xoc Tèrmic (HSP) que actuant de citocines i presentadores d’antígens, inicien la resposta immunològica contra les cèl·lules danyades. Paral·lelament, s’observa un increment de la permeabilitat de la barrera hematoencefàlica degut a la pèrdua de les adhesions cel·lulars estretes per l’alta presència d’espècies reactives. Com a conseqüència de l’afebliment o el trencament de la barrera hematoencefàlica, es pot produir una entrada al SNC de diferents substàncies neurotòxiques i de cèl·lules del sistema immunitàri que, en condicions normals tenen l’accés restringit. Juntament amb aquestes cèl·lules immunològiques, també s’activen les cèl·lules del sistema immunitari innat residents al cervell, la micròglia, i totes elles secreten citocines proinflamatòries que contribueixen al procés de neurodegeneració. Nosaltres presentem els mecanismes pels quals aquesta inflamació, lluny d’atenuar-se, es cronifica per l’acció de certs bucles de retroalimentació positiva. Les diferents peculiaritats de cada malaltia contribueixen en aquest procés de diferents maneres, com és el cas dels pèptids β-amilides en la malaltia d’Alzheimer, l’α-sinucleina en el Parkinson, la superòxid dismutasa (SOD) en l’esclerosi lateral amiotròfica, o l’infiltració de leucòcits al cervell degut a la resposta autoimmune de l’esclerosi múltiple.Deixant de banda aquestes diferències, si el procés és comú entre totes elles, l’estudi a fons d’aquest procés hauria de poder permetre identificar dianes tarapèutiques que siguin comunes per les quatre malalties.

Mesozoic oceanic terranes of southern Central America : geology, geochemistry and gedynamics

Abstract The Northwestern edge of the modern Caribbean Plate, located in central Middle America (S-Guatemala to N-Costa Rica), is characterized by a puzzle of oceanic and continental terranes that belonged originally to the Pacific façade of North America. South of the Motagua Fault Zone, the actual northern strike slip boundary of the Caribbean Plate, three continental slivers (Copán, Chortis s. str. and Patuca) are sandwiched between two complex suture zones that contain HP/LT mafic and ultramafic oceanic rocks: The Motagua Mélanges to the North, extensively studied in the last ten years and the' newly defined Mesquito Composite Oceanic Terrane (MCOT) to the South. No modem geological data were available for the oceanic terrane located in the southern part of the so called continental "Chortis Block". Classically, the southern limit of this block with the Caribbean Large Igneous Province (CLIP) was placed at a hypothetical fault line connecting the main E-W fault in the Santa Elena Peninsula (N-Costa Rica) with the Hess Escarpment. However, our study in eastern Nicaragua and northwestern Costa Rica evidences an extensive assemblage of oceanic upper mantle and crustal rocks outcropping between the Chortis/Patuca continental blocks and the CLIP. They comprise collided and accreted exotic terranes of Pacific origin recording a polyphased tectonic history. We distinguish: 1- The MCOT that comprises a Late Triassic to Early Cretaceous puzzle of oceanic crust and arc-derived rocks set in a serpentinite matrix, and 2- The Manzanillo and Nicoya Terranes that are made of Cretaceous plateau-like rocks associated with oceanic sediments older than the CLIP. This study has been focused on the rocks of the MCOT. The MCOT comprises the southern half of the former "Chortis Block" and is defined by 4 comer localities characterized by ultramafic and mafic oceanic rocks of Late Triassic, Jurassic and Early Cretaceous age: 1- The Siuna Serpentinite Mélange (NE-Nicaragua), 2- The El Castillo Mélange (Nicaragua/Costa Rica border), 3- DSDP Legs 67 and 84 (Guatemala fore-arc basin), and 4- The Santa Elena Peridiotite (NW-Costa Rica). The Siuna Serpentinite Mélange (SSM) is a HP/LT subduction zone mélange set in a serpentinite matrix that contains oceanic crust and arc-related greenschist to blueschist/eclogite facies metamafic and metasedimentary blocks. Middle Jurassic (Bajocian-Bathonian) radiolarites are found in original sedimentary contact with arc-derived greenstones. Late Jurassic black detrital chert possibly formed in a marginal (fore-arc?) basin shortly before subduction. A phengite 40Ar/39Ar -cooling age dates the exhumation of the high pressure rocks as 139 Ma. The El Castillo Mélange (ECM) is composed of serpentinite matrix with OIB metabasalts and Late Triassic (Rhaetian) red and green radiolarite blocks. Recent studies of the DSDP Legs 67/84 show that the Guatemala/Nicaragua fore-arc basin is composed of a pile of ultramafic, mafic (OIB-like) and arc related rocks with ages ranging from Late Triassic to Campanian. Finally, the Santa Elena peridiotites that mark the limit of the MCOT with the Manzanillo/Nicoya Terranes and correspond to an association of ultramafic rocks that comprise peridiotites, dunites and chromites of abyssal and fore-arc origin. The SSM is the result of a collision between a Middle Jurassic island arc and the Patuca Terrane, a fragment of the Western N-American active continental margin. The Siuna Mélange (SSM) and the South Montagna Mélange share common characteristics with the Pacific N-American suture zone (E-Franciscan and Vizcaino mélanges), in particular, the Mesozoic ages of HP/LT metamorphic and the arc-derived blocks. For us, these mélanges imply an originally continuous, but slightly diachronous suture that affected the entire W-American active margin. It may imply the arrival and collision of an exotic intraoceanic arc (Guerrero-Phoenix) related to the origin of the Pacific Plate that initiated as a back arc basin of this arc. The present disposition of the fragments of this suture zone is the result of a northward shift of the active left-lateral strike slip motion between the N-American and the Caribbean Plates. Résumé Le coin nord-ouest de la Plaque Caraïbe moderne se trouve en Amérique Centrale, entre le sud du Guatemala et le nord du Costa Rica. Cette région est composée d'un puzzle de terrains océaniques et continentaux dont les origines se situent sur la façade pacifique de l'Amérique du Nord. Au sud de la faille de Motagua, la limite septentrionale actuelle, décrochante, de la Plaque Caraïbe, se trouvent 3 copeaux continentaux (Copàn, Chortis s. str. et Patuca) coincés entre deux zones de suture complexes à roches mafiques et ultramafiques qui ont subi un métamorphisme de haute pression/basse température (HP/LT). Il s'agit des Mélanges de Motagua au nord, largement étudiés ces dernières années, et du Mesquito Composite Oceanic Terrane (MCOT), récemment défini par nous, au sud. En vue de l'absence de données géologiques modernes concernant les terrains océaniques qui se trouvent dans la partie sud du "Chortis Block" considérée comme continentale, nous avons dédié cette étude à cette région. Classiquement, la limite méridionale entre le "Chortis Block" et la "Caribbean Large Igneous Province" (CLIP) a été associée à une faille hypothétique reliant la faille E-W de Santa Elena (nord du Costa Rica) à l'Escarpement de Hess. Notre étude au Nicaragua oriental et au Costa Rica nord-occidental a révélé l'existence de larges terrains composés d'assemblages de roches mantéliques et océaniques qui se placent entre les blocs continentaux Chortis/Patuca et le CLIP. Ces assemblages révèlent des terrains collisionnés et accrétés d'origine pacifique enregistrant une histoire tectonique polyphasée. Nous distinguons: 1- Le MCOT, un puzzle de roches océaniques d'arc d'âge Triassique supérieur au Crétacée inférieur, 2- Les terrains de Manzanillo et de Nicoya, des morceaux de plateaux océaniques associés à des sédiments océaniques plus âgés que le CLIP. Cette étude se focalisera sur les roches du MCOT. Le MCOT occupe la moitié sud de l'ancien "Chortis Block" et peut se définir par 4 localités de référence qui montrent des roches mafiques et ultramafiques océaniques d'âges compris entre le Trias supérieur et le Crétacée inférieur. 1- Le Siuna Serpentinite Mélange (NE-Nicaragua), 2- Le El Castillo Mélange (Nicaragua/Costa Rica border), 3- Le DSDP Legs 67/84 (Guatemala fore-arc basin) et 4- La Santa Elena Peridiotite (nord-ouest du Costa Rica). Le Siuna Serpentinite Mélange (SSM) est un mélange de subduction HP/BT dans une matrice de serpentinite. On y trouve des éléments de croûte océanique et d'arc insulaire en faciès de schistes verts et schistes bleus. Des radiolarites du Jurassique moyen se trouvent en contact sédimentaire sur des roches vertes d'arc. En revanche, des cherts noirs détritiques datent du Jurassique supérieur et sont probablement issus d'un bassin marginal (fore-arc ?) peu avant leur subduction, car un âge 40Ar/39Ar de refroidissement des phengites date l'exhumation des roches de haute pression à 139 Ma. Le Mélange d'El Castillo (ECM) est constitué d'une matrice serpentinitique et contient des blocs de metabasaltes OIB et des blocs de radiolarites du Trias terminal. Des études récentes ont repris les roches forées lors des DSDP Legs 67 et 84 et montrent que le soubassement du bassin d'avant-arc du Guatemala-Nicaragua est composé de roches ultramafiques et mafiques (OIB et arc), dont les âges isotopiques vont du Trias au Crétacé supérieur. Finalement, les péridiotites de Santa Elena forment la limite sud du MCOT par rapport aux terrains de Manzanillo et Nicoya. Elles contiennent des serpentinites et localement des dunites et chromites à affinité abyssale et de fore-arc. Le SSM témoigne d'une collision entre un arc insulaire d'âge Jurassique moyen et le Patuca Terrane, un fragment de la marge active nord-américaine. Le SSM et le South Motagua Mélange ont des caractéristiques en commun avec les zones de suture de la façade pacifique de l'Amérique du nord (E-Franciscan et Vizcaino mélanges), notamment les âges Mésozoïques du métamorphisme HP/BT et les blocs de roches d'arc. Ce fait nous conduit à penser qu'il s'agit d'une grande zone de suture qui était à l'origine continue sur toute la marge ouest-américaine, mais légèrement diachrone. Cette suture implique l'arrivée et la collision d'un arc intraocéanique exotique (Guerrero-Phoenix) qui est à l'origine de la Plaque Pacifique qui s'ouvrait en back arc par rapport à celui-ci. La disposition actuelle des fragments de cette suture est due à la migration vers le nord du décrochement actif senestre entre la Plaque nord-américaine et la Plaque Caraïbe. K. Flores, 2009 Mesozoic oceanic terranes of southern central America Résumé Grand Public La présente thèse est le résultat de travaux de terrain effectués de 2005 à 2008 au nord-est et au sud du Nicaragua et au nord du Costa Rica, en Amérique Centrale, des analyses pétrologiques et géochimiques en laboratoire ainsi que de la modélisation de l'évolution géodynamique. La région étudiée se situe en bordure nord - ouest de la Plaque Caraïbe moderne. Dans la majorité des publications récentes cette région est représentée comme un vaste bloc continental (le "Bloc Chortis") qui serait limité, (i) au nord, par la faille décrochante de Motagua, la limite actuelle entre la Plaque Nord-Américaine et la Plaque Caraïbe, et (ii) au sud, par une suture hypothétique qui se trouverait aux confins entre le Nicaragua et le Costa Rica. La région du Costa Rica a été considérée presque entièrement comme une partie du Plateau Caraïbe ("Caribbean Large Igneous Province" (CLIP)). L'étude détaillée des affleurements nous a permis de mettre en évidence : - Au nord-est du Nicaragua (Siuna) : Des roches océaniques datées du Jurassique moyen, grâce aux faunes à radiolaires qui ont été extraites des radiolarites rouges. Ces roches ont subi un métamorphisme de haute pression typique des zones de collision. L'étude radio-isotopique Ar/Ar a permis de dater la collision du Crétacé basal (139 Ma). - Au sud du Nicaragua : Des roches océaniques d'âge Trias terminal (200 millions d'années), également datées à l'aide de faunes à radiolaires. Il s'agit actuellement des roches océaniques les plus anciennes connues de l'Amérique Centrale. - L'étude géochimique et les âges des fossiles démontrent que le tiers septentrional du Costa Rica possède un soubassement construit d'au moins deux terrains (Nicoya et Manzanillo), qui ont des caractéristiques de Plateau océanique (Nicoya) et d'arc volcanique du Crétacé moyen (Manzanillo). Ces deux terrains sont plus anciens que le CLIP. En conclusion, nous constatons que la région étudiée est constituée d'un puzzle de 3 blocs continentaux et d'un vaste terrain océanique composite que nous appelons Mesquito Composite Oceanic Terrane (MCOT). En plus, nous définissons les terrains de Nicoya et de Manzanillo comme plus âgés et distincts du CLIP. Le MCOT est caractérisé par la présence de roches du manteau supérieur (les serpentinites) et de la croûte océanique, ainsi que des morceaux d'arcs, d'âge allant du Trias supérieur au Crétacé. Ce terrain est comparable à d'autres zones de suture de la façade pacifique de l'Amérique du nord, notamment en ce qui concerne les âges Mésozoïques, le métamorphisme de haute pression et l'association de roches mantéliques et crustales océaniques. Ce fait nous conduit à penser qu'il s'agit d'une grande zone de suture qui était à l'origine continue sur toute la marge ouest-américaine. Cette suture implique l'arrivée et la collision d'un arc infra-océanique exotique qui serait à l'origine de la Plaque Pacifique qui se serait ouverte en bassin d'arrière arc par rapport à celui-ci. La disposition actuelle des fragments de cette suture est due à la migration vers le nord du décrochement actif senestre entre la Plaque nord-américaine et la Plaque Caraïbe.

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Despite the well-established antitumor activity of CD1d-restricted invariant natural killer T lymphocytes (iNKT), their use for cancer therapy has remained challenging. This appears to be due to their strong but short-lived activation followed by long-term anergy after a single administration of the CD1d agonist ligand alpha-galactosylceramide (αGC). As a promising alternative, we obtained sustained mouse iNKT cell responses associated with prolonged antitumor effects through repeated administrations of tumor-targeted recombinant sCD1d-antitumor scFv fusion proteins loaded with αGC. Here, we demonstrate that CD1d fusion proteins bound to tumor cells via the antibody fragment specific for a tumor-associated antigen, efficiently activate human iNKT cell lines leading to potent tumor cell lysis. The importance of CD1d tumor targeting was confirmed in tumor-bearing mice in which only the specific tumor-targeted CD1d fusion protein resulted in tumor inhibition of well-established aggressive tumor grafts. The therapeutic efficacy correlated with the repeated activation of iNKT and natural killer cells marked by their release of TH1 cytokines, despite the up-regulation of the co-inhibitory receptor PD-1. Our results demonstrate the superiority of providing the superagonist αGC loaded on recombinant CD1d proteins and support the use of αGC/sCD1d-antitumor fusion proteins to secure a sustained human and mouse iNKT cell activation, while targeting their cytotoxic activity and cytokine release to the tumor site.

Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.

The cancer-testis antigen NY-ESO-1 has been targeted as a tumor-associated antigen by immunotherapeutical strategies, such as cancer vaccines. The prerequisite for a T-cell-based therapy is the induction of T cells capable of recognizing the NY-ESO-1-expressing tumor cells. In this study, we generated human T lymphocytes directed against the immunodominant NY-ESO-1(157-165) epitope known to be naturally presented with HLA-A*0201. We succeeded to isolate autorestricted and allorestricted T lymphocytes with low, intermediate or high avidity TCRs against the NY-ESO-1 peptide. The avidity of the established CTL populations correlated with their capacity of lysing HLA-A2-positive, NY-ESO-1-expressing tumor cell lines derived from different origins, e.g. melanoma and myeloma. The allorestricted NY-ESO-1-specific T lymphocytes displayed TCRs with the highest avidity and best anti-tumor recognition activity. TCRs derived from allorestricted, NY-ESO-1-specific T cells may be useful reagents for redirecting primary T cells by TCR gene transfer and, therefore, may facilitate the development of adoptive transfer regimens based on TCR-transduced T cells for the treatment of NY-ESO-1-expressing hematological malignancies and solid tumors.

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.

Enhancing immune responses with immune-modulatory monoclonal antibodies directed to inhibitory immune receptors is a promising modality in cancer therapy. Clinical efficacy has been demonstrated with antibodies blocking inhibitory immune checkpoints such as cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) or PD-1/PD-L1. Treatment with ipilimumab, a fully human CTLA-4-specific mAb, showed durable clinical efficacy in metastatic melanoma; its mechanism of action is, however, only partially understood. This is a study of 29 patients with advanced cutaneous melanoma treated with ipilimumab. We analyzed peripheral blood mononuclear cells (PBMCs) and matched melanoma metastases from 15 patients responding and 14 not responding to ipilimumab by multicolor flow cytometry, antibody-dependent cell-mediated cytotoxicity (ADCC) assay, and immunohistochemistry. PBMCs and matched tumor biopsies were collected 24 h before (i.e., baseline) and up to 4 wk after ipilimumab. Our findings show, to our knowledge for the first time, that ipilimumab can engage ex vivo FcγRIIIA (CD16)-expressing, nonclassical monocytes resulting in ADCC-mediated lysis of regulatory T cells (Tregs). In contrast, classical CD14(++)CD16(-) monocytes are unable to do so. Moreover, we show that patients responding to ipilimumab display significantly higher baseline peripheral frequencies of nonclassical monocytes compared with nonresponder patients. In the tumor microenvironment, responders have higher CD68(+)/CD163(+) macrophage ratios at baseline and show decreased Treg infiltration after treatment. Together, our results suggest that anti-CTLA-4 therapy may target Tregs in vivo. Larger translational studies are, however, warranted to substantiate this mechanism of action of ipilimumab in patients.

The rare cancer network: ongoing studies and future strategy.

The Rare Cancer Network (RCN) was formed in the early 1990's to create a global network that could pool knowledge and resources in the studies of rare malignancies whose infrequency prevented both their study with prospective clinical trials. To date, the RCN has initiated 74 studies resulting in 46 peer reviewed publications. The First International Symposium of the Rare Cancer Network took place in Nice in March of 2014. Status updates and proposals for new studies were heard for fifteen topics. Ongoing studies continue for cardiac sarcomas, thyroid cancers, glomus tumors, and adult medulloblastomas. New proposals were presented at the symposium for primary hepatic lymphoma, solitary fibrous tumors, Rosai-Dorfman disease, tumors of the ampulla of Vater, salivary gland tumors, anorectal melanoma, midline nuclear protein in testes carcinoma, pulmonary lymphoepithelioma-like carcinoma, adenoid cystic carcinoma of the trachea, osteosarcomas of the mandible, and extra-cranial hemangiopericytoma. This manuscript presents the abstracts of those proposals and updates on ongoing studies, as well a brief summary of the vision and future of the RCN.